Zai Lab (ZLAB) Change in Accured Expenses (2020 - 2026)
Zai Lab's (ZLAB) quarterly Change in Accured Expenses came in at -$17.6 million in Q1 2026, up 24.22% year-on-year from -$14.2 million in Q1 2025, and down 253.12% quarter-over-quarter from $11.5 million in Q4 2025.
Zai Lab (ZLAB) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Change in Accured Expenses across 7 years of filings, most recently posting -$17.6 million for Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$17.6 million, up 24.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (up 193.64% YoY), and the FY2025 annual result was $4.8 million, up 121.57% from the prior year.
- Change in Accured Expenses came in at -$17.6 million for Q1 2026 at Zai Lab, down from $11.5 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $19.6 million in Q4 2023 to a low of -$34.2 million in Q1 2024.
- The 5-year median for Change in Accured Expenses is $5.7 million (2022), against an average of -$453411.8.
- Across the five-year window, Change in Accured Expenses tumbled 140.71% in 2022 and soared 836.09% in 2025, its largest moves.
- Zai Lab's Change in Accured Expenses stood at $5.8 million in 2022, then surged by 239.75% to $19.6 million in 2023, then slipped by 24.26% to $14.8 million in 2024, then decreased by 22.34% to $11.5 million in 2025, then slumped by 253.12% to -$17.6 million in 2026.
- The last three Change in Accured Expenses figures came in at -$17.6 million (Q1 2026), $11.5 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | -17.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.64 Mn |
| Mar 31, 2026 | -17.64 Mn |
| Dec 31, 2025 | 11.52 Mn |
| Dec 31, 2025 | 11.52 Mn |
| Sep 30, 2025 | 9.18 Mn |
| Sep 30, 2025 | 9.18 Mn |
| Jun 30, 2025 | 7.33 Mn |
| Jun 30, 2025 | 7.33 Mn |
| Mar 31, 2025 | -23.28 Mn |
| Mar 31, 2025 | -23.28 Mn |
| Dec 31, 2024 | 14.83 Mn |
| Dec 31, 2024 | 14.83 Mn |
| Sep 30, 2024 | -1.25 Mn |
| Sep 30, 2024 | -1.25 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -34.20 Mn |
| Mar 31, 2024 | -34.20 Mn |
| Dec 31, 2023 | 19.58 Mn |
| Dec 31, 2023 | 19.58 Mn |